Three cases of congenital dysfibrinogenemia in unrelated Chinese families

Abstract

Congenital dysfibrinogenemia (CD) is a qualitative fibrinogen disorder caused by an abnormal fibrinogen molecule structure, leading to dysfunctional blood coagulation. This study describes 3 cases of dysfibrinogenemia identified in the unrelated Chinese pedigrees.Routine coagulation screening tests were performed on the probands and their families. The antigens and functionality of fibrinogen was measured using an immunoturbidimetry assay and the Clauss method, respectively. To identify the genetic mutation responsible for these dysfibrinogens, genomic DNA extracted from the blood was analyzed using PCR amplification and direct sequencing. The presence of the mutant chains was determined using matrix-assisted laser desorption/ionization time of flight (MALDI-TOF) mass spectroscopy. Purified plasma fibrinogen of 3 probands was analyzed using SDS–PAGE, fibrinogen clottability, fibrin polymerization, fibrinopeptide release, and scanning electron microscopy (SEM).The 3 probands had a long thrombin time. Levels of functional fibrinogen were found to be very low, while the fibrinogen antigen was within the normal range. DNA sequencing revealed a heterozygous Arg16His substitution in the fibrinogen Aα chain (FGA). The mutant chains were found to be expressed using MALDI-TOF mass spectroscopy. SDS–PAGE did not reveal any difference in the molecular weights of 3 polypeptide chains between normal and abnormal fibrinogens. Fibrinogen clottability showed a slower fibrin clot formation than the healthy control. Fibrin polymerization, after addition of thrombin, showed a prolonged lag phase and decreased final turbidity. The kinetics of fibrinopeptides release revealed a decreased amount of the released fibrinopeptide A. SEM of the patient's fibrin clot was found to be abnormal.Results indicate that the 3 probands with dysfibrinogenemia were caused by mutations of Aα chain Arg16His. Mutation of this fibrinogen induced dysfunction of plasma fibrinogen.

<p>Non-Adherence to Prescribed Antihypertensives in Primary, Secondary and Tertiary Healthcare Settings in Islamabad, Pakistan: A Cross-Sectional Study</p>

“…28 Various studies conducted in different Asian countries, ie China, Hong Kong, Saudi Arabia, UAE and Iran, using MMAS-8 have also reported similar poor adherence to prescribed antihypertensive therapy, supporting our results. 15,[29][30][31][32][33][34][35] The WHO estimates the prevalence of non-adherence among patients with chronic diseases to be between 52% and 74%, defined by ≥80% cut-off. 36 In this study, we found no significant correlation between gender and medication adherence.…”

“…Optimal adherence to prescribed antihypertensive therapy may result in substantial reductions in the incidence of myocardial infarction (20-25%), heart failure (>50%) and stroke (35-40%). 15,16 Various barriers to antihypertensive medication adherence have been previously identified and reported in the literature. These include cost of medication, lack of education, forgetfulness, unavailability, too much medication, fear of addiction and possible side effects, and dissatisfaction with the therapy.…”

PD-1 signaling modulates interferon-γ production by Gamma Delta (γδ) T-Cells in response to leukemia

“…Studies analyzing the immune cell repertoire in healthy adults found that PD-1 expression is higher in Vδ1+, compared to Vδ2 + T-cells 15 but similar within several functionally distinctive subsets of Vδ2 T-cells. 16 Others reported differences in PD-1 expression depending on CD27 and CD45RA status with preferential expression in the effector-memory subsets.…”

“…7 Patients with common variable immunodeficiency (CVID) have less Vδ2 T-cells but the remaining cells express more PD-1. 15 In cancer, higher expression of PD-1 was described in γδ T-cells isolated from neuroblastoma 14 and colorectal cancer tissues 17 as well as multiple myeloma (MM) infiltrated BM. 6 Daley et al examined immune cell infiltration of pancreatic ductal adenocarcinoma tissues in humans and found that γδ T-cells were highly enriched compared to normal pancreas.…”

<p>Detection of Secondary Metabolites as Biomarkers for the Early Diagnosis and Prevention of Type 2 Diabetes</p>

“…16,21 Bile acid (BA) metabolism was reported to be involved in cholesterol as well as glucose metabolism homeostasis. 29 The latter authors claimed that insulin resistance is positively associated with hyperbileacidemia regardless of diabetes status, which indicates the important role of insulin resistance in the regulation of "bile secretion" pathway in human. BAs also exert a variety of metabolic reactions as they likely promote the secretion of incretin in the digestive tract, improve glucose tolerance, promote insulin secretion, thus positively increase insulin sensitivity.…”